{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:09Z","timestamp":1792790589686,"version":"4.5.0"},"reference-count":15,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SPI"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:sec>\n<jats:title>OBJECTIVE<\/jats:title>\n<jats:p>Tranexamic acid (TXA), a synthetic antifibrinolytic drug, has been reported to reduce blood loss in orthopedic surgery, but there have been few reports of its use in spine surgery. Previous studies included limitations in terms of different TXA dose regimens, different levels and numbers of fused segments, and different surgical techniques. Therefore, the authors decided to strictly limit TXA dose regimens, surgical techniques, and fused segments in this study. There have been no reports of using TXA for prevention of intraoperative and postoperative blood loss in posterior lumbar interbody fusion (PLIF). The purpose of the study was to evaluate the efficacy of high-dose TXA in reducing blood loss and its safety during single-level PLIF.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>METHODS<\/jats:title>\n<jats:p>The study was a nonrandomized, case-controlled trial. Sixty consecutive patients underwent single-level PLIF at a single institution. The first 30 patients did not receive TXA. The next 30 patients received 2000 mg of intravenous TXA 15 minutes before the skin incision was performed and received the same dose again 16 hours after the surgery. Intra- and postoperative blood loss was compared between the groups.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>RESULTS<\/jats:title>\n<jats:p>There were no statistically significant differences in preoperative parameters of age, sex, body mass index, preoperative diagnosis, or operating time. The TXA group experienced significantly less intraoperative blood loss (mean 253 ml) compared with the control group (mean 415 ml; p &lt; 0.01). The TXA group also had significantly less postoperative blood loss over 40 hours (mean 321 ml) compared with the control group (mean 668 ml; p &lt; 0.01). Total blood loss in the TXA group (mean 574 ml) was significantly lower than in the control group (mean 1080 ml; p &lt; 0.01). From 2 hours to 40 hours, postoperative blood loss in the TXA group was consistently significantly lower. There were no perioperative complications, including thromboembolic events.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>CONCLUSIONS<\/jats:title>\n<jats:p>High-dose TXA significantly reduced both intra- and postoperative blood loss without causing any complications during or after single-level PLIF.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2016.8.spine16528","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T15:04:18Z","timestamp":1480086258000},"page":"363-367","source":"Crossref","is-referenced-by-count":38,"title":["High-dose tranexamic acid reduces intraoperative and postoperative blood loss in posterior lumbar interbody fusion"],"prefix":"10.3171","volume":"26","author":[{"given":"Junichi","family":"Kushioka","sequence":"first","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka University Graduate School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Rosai Hospital; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Okuda","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Rosai Hospital; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Maeno","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Rosai Hospital; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomiya","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Rosai Hospital; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Police Hospital, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Osaka Rosai Hospital; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-spine16528","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.spinee.2015.01.013","article-title":"Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis","volume":"15","author":"Cheriyan T,","year":"2015","unstructured":"Cheriyan T, Maier SP II, Bianco K, Slobodyanyuk K, Rattenni RN, Lafage V, : Efficacy of tranexamic acid on surgical bleeding in spine surgery: a meta-analysis. Spine J 15:752\u2013761, 201510.1016\/j.spinee.2015.01.01325617507"},{"issue":"6 Suppl","key":"b2-spine16528","series-title":"Chest","doi-asserted-by":"publisher","first-page":"299S","DOI":"10.1007\/s00586-004-0716-2","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Douketis JD,","year":"2008","unstructured":"Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, : The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:6 Suppl299S\u2013339S, 200810.1007\/s00586-004-0716-2"},{"key":"b3-spine16528","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1097\/BRS.0b013e318188b9c5","article-title":"Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study","volume":"33","author":"Elwatidy S,","year":"2008","unstructured":"Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A: Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976) 33:2577\u20132580, 20081901153810.1097\/BRS.0b013e318188b9c5"},{"key":"b4-spine16528","series-title":"Ann R Coll Surg Engl","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1378\/chest.08-0675","article-title":"Factors affecting the fibrinolytic response to surgery","volume":"61","author":"Griffiths NJ:","year":"1979","unstructured":"Griffiths NJ: Factors affecting the fibrinolytic response to surgery. Ann R Coll Surg Engl 61:12\u201316, 19798454610.1378\/chest.08-0675"},{"key":"b5-spine16528","series-title":"Can J Anaesth","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF03009046","article-title":"Natural and synthetic antifibrinolytics in cardiac surgery","volume":"39","author":"Hardy JF,","year":"1992","unstructured":"Hardy JF, Desroches J: Natural and synthetic antifibrinolytics in cardiac surgery. Can J Anaesth 39:353\u2013365, 1992137334610.1007\/BF03009046"},{"key":"b6-spine16528","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1007\/s00586-013-2774-9","article-title":"Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials","volume":"22","author":"Li ZJ,","year":"2013","unstructured":"Li ZJ, Fu X, Xing D, Zhang HF, Zang JC, Ma XL: Is tranexamic acid effective and safe in spinal surgery? A meta-analysis of randomized controlled trials. Eur Spine J 22:1950\u20131957, 20132365762310.1007\/s00586-013-2774-9"},{"issue":"Suppl 1","key":"b7-spine16528","series-title":"Eur Spine J","first-page":"S62","article-title":"Tranexamic acid for major spinal surgery","volume":"13","author":"Neilipovitz DT:","year":"2004","unstructured":"Neilipovitz DT: Tranexamic acid for major spinal surgery. Eur Spine J 13:Suppl 1S62\u2013S65, 2004"},{"issue":"Suppl 2 Pt 2","key":"b8-spine16528","series-title":"J Bone Joint Surg Am","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2106\/00004623-200709001-00013","article-title":"Surgical outcomes of posterior lumbar interbody fusion in elderly patients. Surgical technique","volume":"89","author":"Okuda S,","year":"2007","unstructured":"Okuda S, Oda T, Miyauchi A, Haku T, Yamamoto T, Iwasaki M: Surgical outcomes of posterior lumbar interbody fusion in elderly patients. Surgical technique. J Bone Joint Surg Am 89:Suppl 2 Pt 2310\u2013320, 20071776822410.2106\/00004623-200709001-00013"},{"key":"b9-spine16528","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.spinee.2013.10.014","article-title":"Trends in the surgical treatment of lumbar spine disease in the United States","volume":"15","author":"Pannell WC,","year":"2015","unstructured":"Pannell WC, Savin DD, Scott TP, Wang JC, Daubs MD: Trends in the surgical treatment of lumbar spine disease in the United States. Spine J 15:1719\u20131727, 201510.1016\/j.spinee.2013.10.01424184652"},{"key":"b10-spine16528","series-title":"Eur J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00554669","article-title":"Pharmacokinetics and bioavailability of tranexamic acid","volume":"20","author":"Pilbrant A,","year":"1981","unstructured":"Pilbrant A, Schannong M, Vessman J: Pharmacokinetics and bioavailability of tranexamic acid. Eur J Clin Pharmacol 20:65\u201372, 198110.1007\/BF005546697308275"},{"key":"b11-spine16528","series-title":"J Bone Joint Surg Br","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1302\/0301-620X.83B5.11745","article-title":"Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee","volume":"83","author":"Tanaka N,","year":"2001","unstructured":"Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S: Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 83:702\u2013705, 20011147630910.1302\/0301-620X.83B5.11745"},{"key":"b12-spine16528","series-title":"Spine (Phila Pa 1976)","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1097\/BRS.0b013e3181fb3a42","article-title":"Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: a prospective randomized study","volume":"36","author":"Tsutsumimoto T,","year":"2011","unstructured":"Tsutsumimoto T, Shimogata M, Ohta H, Yui M, Yoda I, Misawa H: Tranexamic acid reduces perioperative blood loss in cervical laminoplasty: a prospective randomized study. Spine (Phila Pa 1976) 36:1913\u20131918, 201110.1097\/BRS.0b013e3181fb3a4221289587"},{"key":"b13-spine16528","series-title":"Eur Spine J","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s00586-013-2836-z","article-title":"Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial","volume":"22","author":"Wang Q,","year":"2013","unstructured":"Wang Q, Liu J, Fan R, Chen Y, Yu H, Bi Y, : Tranexamic acid reduces postoperative blood loss of degenerative lumbar instability with stenosis in posterior approach lumbar surgery: a randomized controlled trial. Eur Spine J 22:2035\u20132038, 201310.1007\/s00586-013-2836-z23715891"},{"key":"b14-spine16528","series-title":"PLoS One","doi-asserted-by":"publisher","first-page":"e55436","DOI":"10.1371\/journal.pone.0055436","article-title":"Systematic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgery","volume":"8","author":"Yang B,","year":"2013","unstructured":"Yang B, Li H, Wang D, He X, Zhang C, Yang P: Systematic review and meta-analysis of perioperative intravenous tranexamic acid use in spinal surgery. PLoS One 8:e55436, 20132342463210.1371\/journal.pone.0055436"},{"key":"b15-spine16528","series-title":"Spine J","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.spinee.2014.09.026","article-title":"National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009","volume":"15","author":"Yoshihara H,","year":"2015","unstructured":"Yoshihara H, Yoneoka D: National trends in the surgical treatment for lumbar degenerative disc disease: United States, 2000 to 2009. Spine J 15:265\u2013271, 20152528192010.1016\/j.spinee.2014.09.026"}],"container-title":["Journal of Neurosurgery: Spine"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/26\/3\/article-p363.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/26\/3\/article-p363.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-spine\/26\/3\/article-p363.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T22:25:30Z","timestamp":1681597530000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-spine\/26\/3\/article-p363.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":15,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2016.8.spine16528","relation":{},"ISSN":["1547-5654"],"issn-type":[{"value":"1547-5654","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}